Friedman Industries, Incorporated (NYSEMKT:FRD) shares moved up 2.26% in last trading session and ended the day at $4.52. FRD Gross Margin is 4.90%. Friedman Industries, Incorporated (NYSEMKT:FRD) quarterly performance is -23.93%.
The Board of Directors of Friedman Industries, Incorporated (NYSEMKT: FRD), a Texas-based company engaged in pipe manufacturing, steel processing and steel and pipe distribution, declared on December 1, 2015, a cash dividend of $0.01 per share on the Common Stock of the Company. The Company will pay the cash dividend on February 12, 2016, to shareholders of record at the close of business on January 15, 2016.
Synovus Financial Corporation (NYSE:SNV) ended the last trading day at $28.05. Company weekly volatility is calculated as 3.75% and price to cash ratio as 2.90. Synovus Financial Corporation (NYSE:SNV) showed a weekly performance of -3.28%.
Synovus Financial Corp. (NYSE:SNV) reported financial results for the quarter ended December 31, 2015. Net income available to common shareholders for the fourth quarter of 2015 was $55.8 million or $0.43 per diluted share as compared to $55.4 million or $0.42 per diluted share for the third quarter of 2015 and $50.6 million or $0.37 per diluted share for the fourth quarter of 2014. Adjusted earnings per diluted share for the fourth quarter of 2015 were $0.44, a 4.2% increase from the third quarter of 2015 and a 13.5% increase from the fourth quarter of 2014.
On 21 January, M&T Bank Corporation (NYSE:MTB) shares fell -2.38% and was closed at $102.24. MTB EPS growth in last 5 year was 20.80%. M&T Bank Corporation (NYSE:MTB) year to date (YTD) performance is -15.63%.
On 19 January, M&T Bank Corp. (NYSE:MTB) reported fourth-quarter net income of $271 million. The Buffalo, New York-based bank said it had earnings of $1.65 per share. The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.93 per share. The bank holding company posted revenue of $1.26 billion in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $1.25 billion.
Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) shares fell -6.54% in last trading session and ended the day at $72.71. EGRX Gross Margin is 67.40% and its has a return on assets of -4.00%. Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) quarterly performance is 10.35%.
On 11 January, Eagle Pharmaceuticals (NASDAQ:EGRX) and AMRI (AMRI) announced that they have entered into an agreement to jointly develop and manufacture several select and complex parenteral drug products for registration and subsequent commercialization in the United States, which will significantly expand Eagle’s portfolio of existing products and product candidates targeting therapeutic areas including oncology, critical care and orphan diseases.
Agenus Inc. (NASDAQ:AGEN) caters to the Healthcare space. Its weekly performance is 5.50%. On the last day of trading company shares ended up at $3.45. Agenus Inc. (NASDAQ:AGEN) distance from 50-day simple moving average (SMA50) is -14.70%.
Agenus Inc. (NASDAQ:AGEN), announced that the U.S. Food and Drug Administration (FDA) cleared the company’s investigational new drug (IND) application for AGEN1884, an immune checkpoint modulator (CPM) antibody that binds to cytotoxic T-lymphocyte antigen-4 (CTLA-4). Clearance was also received for a second CPM antibody partnered with Incyte (INCY) for INCAGN1876, which targets glucocorticoid-induced TNFR-related protein (GITR). Clinical trials for both candidates are expected to begin in the first half of 2016.
Leave a Reply